{"id":51478,"name":"FLAGSHIP PIONEERING","slug":"flagship-pioneering","state":"MA","country":"United States of America","description":"Pioneering scientists building companies to transform health & agricultural sustainability","totalSpending":1280000,"filings":17,"yearlySpending":[{"year":2022,"income":320000},{"year":2023,"income":320000},{"year":2024,"income":320000},{"year":2025,"income":320000}],"issues":["HCR","BUD"],"firms":["TARPLIN, DOWNS & YOUNG, LLC"],"lobbyists":["CHARLOTTE IVANCIC","EMILY MURRY","MICHELLE EASTON","ELIZABETH MURRAY","JENNIFER YOUNG","RAISSA DOWNS","KIMBERLY BRANDT","PAMELA SMITH","MARGARET JOSEPH","PETER FISE","LAURA FRIEDEL","PARICK CARROLL"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","White House Office","Centers For Medicare and Medicaid Services (CMS)","Food & Drug Administration (FDA)","Commerce, Dept of (DOC)","Office of Management & Budget (OMB)"],"sampleDescriptions":["healthcare innovation and access","Pandemic preparedness, FDA policy issues, ARPA-H, innovation, preemptive health and medicine","Pandemic preparedness, FDA policy issues, ARPA-H, life science innovation and competitiveness, preemptive health and medicine, long COVID research","Pandemic preparedness, FDA policy issues, ARPA-H, life science innovation and competitiveness, preemptive health and medicine, long COVID research, biomanufacturing, next generation vaccines therapeut","Pandemic preparedness, FDA policy issues, ARPA-H, life science innovation and competitiveness, preemptive health and medicine, long COVID research, biomanufacturing, next generation vaccines therapeut"],"years":[2022,2023,2024,2025]}